The 4-1BB (CD137) arm acts as a costimulatory agonist on T cells, enhancing their activation. GNC-035 redirects CD3+ T cells to kill ROR1+ tumor cells (with PD-L1 blockade relieving inhibition); 4-1BB–expressing cells themselves are not targeted for lysis.